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Anaesthesia, Juliane Marie Center, Copenhagen University Hospital (Rigshospitalet),  Copenhagen , Denmark 
tients set for lumbar puncture in Danish haematology de-
partments. The diversity may be explained by and related to 
different opinions in the literature. Common national guide-
lines are warranted and there is a need for studies to estab-
lish an evidence-based approach for the management of pa-
tients at risk of bleeding when lumbar puncture or another 
invasive procedure is indicated.  © 2014 S. Karger AG, Basel 
 Across all medical disciplines, when performing lum-
bar dural puncture (LP), haemostatic management is in-
creasingly a matter of concern due to a rising prevalence 
of antithrombotic therapy. In 2012, 9.6% of all Danes re-
ceived prophylaxis against thrombosis  [1] , and the treat-
ment is administered with an increasing variety of drugs 
targeting platelets and different steps in the coagulation 
cascade. Additionally, even in the absence of prophylaxis, 
haematology patients may have an increased bleeding 
risk due to low platelet counts or abnormal platelet func-
tion.
 In haematology, LP is used for therapeutic (i.e. admin-
istration of cytotoxic drugs) and diagnostic purposes (i.e. 
clarification of disease involvement in leukemia or lym-
phoma). A diagnostic LP can also be performed to dem-
onstrate viral or bacterial meningitis, or complications 
 Key Words 
 Anticoagulants · Lumbar puncture · Ophthalmoscopy ·
Platelet aggregation inhibitors · Questionnaires · 
Spinal epidural haematoma · Subdural haematoma · 
Thrombocytopenia · Tonsillar herniation  
 Abstract 
 Background/Aims: Thrombocytopenia and the increasing 
use and variety of antithrombotic drugs is a challenge prior 
to lumbar puncture. This study examined the Danish haema-
tology practice regarding drug pausation, assessment of 
haemostasis and whether fundoscopy is a routine safety 
measure.  Methods: An online survey with questions pertain-
ing to precautions of haemostasis and application of fundos-
copy was sent by e-mail to all 12 haematology wards in Den-
mark.  Results: Eleven sites participated. Five (45%) reported 
no pausation of antiplatelet drugs at all. The mean platelet 
limit prior to lumbar puncture was 50 × 10 9 /l (range 10–50 × 
10 9 /l). Seven (64%) sites had an international normalised ra-
tio limit of 1.5, and the remaining 4 had values between 1.0 
and 2.5. Two (18%) reported occasional use of thromboelas-
tography or platelet analysis to assess the bleeding risk. Fun-
doscopy is routinely performed in 4 (36%) departments. 
 Conclusion: We report considerable variation in the routine 
handling of antithrombotics and thrombocytopenia in pa-
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like Guillian-Barré syndrome, which immunosuppressed 
or neutropenic patients are predisposed to.
 Complications following LP include post-dural punc-
ture headache, back pain, neck stiffness, nausea, photo-
phobia, hearing loss and other cranial nerve palsies  [2] . 
Potentially life-threatening or debilitating complications 
like haematomas, incarceration and infections are rare  [3, 
4] . More recent guidelines have focused on the risk of spi-
nal haematoma in spinal anaesthesia  [5, 6] , a feared se-
quel often associated with impaired haemostasis  [4] . 
Once present, permanent paraplegia can ensue even after 
surgical decompression  [4] , and permanent deficits have 
been reported in up to 90% of cases  [5] . The haematology 
population, in particular patients treated by haematopoi-
etic stem cell transplantation, may be at an increased risk 
of developing cranial subdural haematoma  [7, 8] .
 Arterial and venous thrombi are major causes of mor-
bidity and mortality. Thus, performing LP in patients re-
ceiving antithrombotic drugs is complex, and the use of 
para-clinical assessment to predict the risk of bleeding 
remains a challenge because of the poor predictive value 
of the current tests  [9, 10] .
 This study aimed to describe LP practice in a haematol-
ogy context with regard to haemostatic safety measures 
and whether fundoscopy is routinely performed. We dis-
cuss the results of a survey in light of the current evidence 
and give an overview of the possible complications. Al-
though the present article focuses on haematology wards 
in Denmark, it may very well prove useful for and give 
perspective to physicians in other specialties and interna-
tionally.
 Methods 
 A survey was created electronically. It was disseminated to a 
senior colleague at each of the 12 haematology wards in Denmark 
in March 2012.
 The questions referred to routine pausation of antithrombotic 
drugs, the choice of para-clinical tests to assess the bleeding risk 
and the application of fundoscopy.
 All questions were multiple-choice, giving predefined intervals 
for the answers. Submission was not permitted without a 100% 
response rate.
 Results 
 Data from 11 of the 12 invited sites were collected in 
April 2012 and the survey was closed for further access. 
One department declined to participate because LP is a 
rare procedure at that unit.
 The results are presented referring to the platelet count 
as the limit before LP ( fig. 1 ) and the therapeutic precau-
tions taken before LP ( table 1 ).
 Figure 1 shows a wide variation in the reported lowest 
acceptable limit for platelet counts on the day of LP 
( fig. 1 ). The results illustrate the limit at which a patient 
in that particular department would receive platelet trans-
fusion before LP, when evaluated based on the platelet 
count. Our survey did not ask for the number of platelet 
transfusions given when the platelet count was below the 
acceptable limit prior to LP.
 Table 1 presents the results of therapeutic precautions if 
patients on antithrombotic therapy were scheduled for LP. 
The results show a broad range with regard to the timing of 
vitamin K antagonists and platelet inhibitor cessation. 
Thromboelastography (TEG) and platelet function analy-
sis (PFA) were not found to be common practice among 
Danish haematologists. Fundoscopy prior to LP was a rou-
tine procedure at less than half of the 11 departments.
 Discussion 
 Our survey is the first national questionnaire in hae-
matology in Denmark to collect data on a clinical proce-
dure. The results show that the evaluation of haemostasis 
and safety measures, such as the platelet limit on the day 
of LP, cessation of antithrombotic therapy and perfor-
mance of a fundoscopy, varies greatly as reflected by the 
controversies in the current literature described below.
 Our search for ‘an acceptable platelet count’ was per-
formed to gain knowledge about the ‘critical limit’ for 
when LP are performed and considered to be safe ( fig. 1 ). 
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 Fig. 1. Lowest acceptable limit of platelets on the day of lumbar 
puncture (×10 9 /l). 
D
ow
nl
oa
de
d 
by
: 
80
.1
63
.3
3.
95
 - 
3/
19
/2
01
7 
11
:3
4:
16
 P
M
 Møller  /Bjerrum  /Afshari  
 
Acta Haematol 2015;133:108–112
DOI: 10.1159/000362357
110
The results showed a 5-fold range of platelet limits as the 
clinical guideline in the 11 departments. In 6 depart-
ments, platelets would be administered at a level below
50 × 10 9 /l, in 3 departments at 20 × 10 9 /l or below and in 
2 departments at 10 × 10 9 /l ( fig.  1 ). This demonstrates 
that the use of platelet transfusion varies considerably. LP 
can be carried out safely based solely on the platelet count 
and at levels as low as 40 × 10 9 /l  [6] . However, since the 
platelet count is not re-analysed routinely following 1 or 
2 platelet transfusions, the risk of a haemorrhagic adverse 
event in individual patients is difficult to assess.
 It was not the aim of this study to examine the frequen-
cy of complications following LP. Furthermore, we were 
unable to determine whether different attitudes towards 
the lowest acceptable platelet limit may yield differing 
safety profiles. This would require extensive data most 
likely exceeding several years of procedures with com-
plete follow-up.
 The risk of spinal haematoma following diagnostic LP 
remains to be determined. However, it has been extensive-
ly studied in anaesthetic procedures, with recent estimates 
of 1: 100,000 after epidural labor analgesia and 1: 3,600
in female orthopedic patients for epidural analgesia and
1: 22,000 for spinal anaesthesia  [5] . A sudden onset of in-
tense, knife-like back pain should arouse suspicion  [4] . The 
pain can be absent  [5] or may be followed in some cases by 
a pain-free interval of minutes to days, after which there is 
progressive paralysis below the affected spinal level and/or 
sensory changes and incontinence  [4] . Prompt magnetic 
resonance imaging is paramount, as a delay in diagnosis 
has been associated with a poor prognosis  [3, 5, 11] . The 
treatment of choice is surgical decompression  [3, 4] .
 Cranial subdural haematoma is a known complication 
of haematopoietic stem cell transplantation  [7, 8] , diag-
nostic LP  [12] and spinal anaesthesia  [13] . Diagnosis is 
complicated by the fact that the symptoms resemble those 
of post-dural puncture headache, viral meningitis, corti-
cal vein thrombosis and sinus headache  [12] and by the 
fact that an initial normal brain imaging may not neces-
sarily rule out a cranial subdural haematoma. Repeated 
computed tomography has been shown to be necessary in 
haematology patients  [7] .
 Moreover, it has been hypothesised that the pathogen-
eses of post-dural puncture headache and this spontane-
ous or ‘non-traumatic’ subdural haematoma are similar 
due to cerebrospinal fluid leakage from the puncture site 
 [12] . Dural puncture may be the first link in a chain of 
adverse events ultimately leading to cranial subdural hae-
matoma, which can be avoided by following a series of 
simple recommendations  [2, 14] . These include prevent-
ing post-dural puncture headache via the use of an atrau-
matic needle  [2, 15] and treating the condition with an 
epidural blood patch  [14] .
 Symptoms of cranial subdural haematoma include re-
duced consciousness, focal neurological signs and pro-
longed and prominent headache  without postural fea-
tures  [3] as opposed to post-dural puncture headache  [2, 
3] . It has been reported that patients may develop subdu-
ral haematoma before regeneration in haematopoietic 
stem cell transplantation when severe thrombocytopenia 
is a strong risk factor  [7] .
 Table 1.  Haemostatic precautions and fundoscopy (n = 11)
Question n (%)
Pausation of LMWH prior to LP
12 – 24 h depending on the dosage 5 (45)
LMWH is not used in connection with LP 0 (0)
Adhering to guidelines from the DSTH and/or with
support from a coagulation specialist. 6 (55)
Pausation with vitamin K antagonists prior to LP
1 day 1 (9)
2 days 1 (9)
3 days 7 (64)
4 days 1 (9)
5 days 1 (9)
Maximal INR value on the day of sampling
1.0 1 (9)
1.2 1 (9)
1.5 7 (64)
2.0 1 (9)
2.5 1 (9)
Routine pausation of platelet inhibitors1 (days not specified)
None 5 (45)
Aspirin 3 (27)
Persantine 4 (36)
Asasantine 4 (36)
Clopidogrel 6 (55)
Other2 1 (9)
Use of other para-clinical tests when in doubt about the risk of 
bleeding1
Thromboelastography (e.g. TEG or ROTEM) 2 (18)
Platelet analysis (e.g. Multiplate or PFA-100) 1 (9)
No, never 9 (82)
Not available at the department 1 (9)
Routine fundoscopy prior to LP
Yes 4 (36)
No 7 (64)
 The survey can be viewed at: dl.dropbox.com/u/456627/sur-
vey.pdf. LMWH = Low-molecular-weight heparin; DSTH = Da-
nish Society of Thrombosis and Haemostasis. 
1 Multiple selections allowed. 2 One department specifically 
mentioned ticagrelor.
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 According to a recent systematic review, a platelet lev-
el of 40 × 10 9 /l is considered ‘safe’ for LP, provided that 
the count is stable, that no concomitant antithrombotic 
therapy is given, that no other acquired or congenital co-
agulopathy is present and that the platelets are well func-
tioning  [6] . This concept may have a great impact since 
the rates of bleeding events have been shown to differ be-
tween haematologic diseases and the etiology of the 
thrombocytopenia  [16] . Platelet counts below 40 × 10 9 /l 
may also be safe, but there is insufficient data to make 
recommendations for such strategies. In case of platelet 
levels of 20–40 × 10 9 /l in patients requiring LP, an indi-
vidual decision based on an assessment of the risks and 
benefits is warranted  [6] .
 A minimum 7-day pause of clopidogrel is often recom-
mended because of considerable and irreversible platelet 
inhibition  [3, 5] . Dipyridamol and low-dose aspirin as a 
single therapy appear to have little impact on the bleeding 
risk and can thus be continued  [3, 5, 11] . Only 6 (55%) of 
the survey respondents adhered to the above, as the re-
maining 5 submitted having no routine pausation of anti-
platelet drugs. However, this disparity should be viewed in 
the context of various aspects. First, as a routine measure, 
most haematology patients have already had their anti-
thrombotic medication paused for several days prior to LP 
because of a pathological or cytotoxicity-induced nadir 
state. Secondly, the handling of haematopoietic stem cell 
transplants and acute leukemia is centralised to 5 haema-
tology wards. Thus, considering the term ‘routine prac-
tice’, some perform LP on a daily basis while other depart-
ments have less than 25 LP annually  [15] . Finally, LP is 
only contraindicated if the risk of the procedure outweighs 
the potential benefit. Given that the potential benefit might 
be higher in a leukemic patient, in whom postponement of 
the diagnosis and treatment may be detrimental – as op-
posed to elective surgery – one may argue that a greater 
risk may be accepted. Haematology patients for whom an-
tiplatelet drugs have not been discontinued may still qual-
ify for LP. Conversely, clopidogrel treatment, e.g. via a 
drug-eluting stent, can contraindicate a pause and thus 
suggests postponement of the LP in other settings  [17] .
 An international normalised ratio (INR) limit of 1.5 is 
preferred, as reflected by our questionnaire and the lit-
erature  [3, 5, 11] . However, this limit is arbitrary and no 
‘safe’ INR threshold has yet been determined to guide 
clinical high-risk procedures such as LP, neurosurgery 
and liver biopsy  [3, 5, 11] .
 Para-clinical assessment of the risk of bleeding in pa-
tients with coagulopathy remains a challenge because of 
the poor predictive value of the available tests. Neither 
platelet counts nor activated partial thromboplastin times 
or INR  [9] provide information about platelet function. 
TEG (e.g. TEG ® or ROTEM ® ) represents a whole-blood 
coagulation monitor that can be a useful tool to deter-
mine coagulation and fibrinolysis function and detect al-
terations in platelet aggregation  [10] . PFA (e.g. PFA-100 ® 
or Multiplate ® ) is an alternative bedside assay of coagula-
tion that specifically evaluates platelet function and may 
be superior in detecting platelet dysfunction in patients 
with a positive bleeding anamnesis. The information ob-
tained from TEG or PFA could be used in conjunction 
with usual coagulation tests to determine if adequate co-
agulation is present before LP  [9] . However, no available 
method has been able to provide high predictive values 
for bleeding risk  [10] .
 TEG and PFA are not commonly used by Danish hae-
matologists ( table 1 ) despite their widespread availability 
on a national basis. Whether routine use of TEG and PFA 
will lead to an increase or a decrease in platelet transfu-
sion and perhaps to fewer bleeding events remains to be 
determined.
 Our survey showed that fundoscopy is not practiced 
before LP in the majority of haematology departments 
( table 1 ). Routine fundoscopy is disputed because it is dif-
ficult to perform or interpret and increased intracranial 
pressure may be present without papilledema  [18] . Thus, 
a normal fundoscopy may lead to false reassurance  [19] . 
In addition, increased intracranial pressure in itself will 
not lead to incarceration, except in certain circumstances 
where a pressure gradient has developed  [3] . Current re-
views and guidelines instead recommend a cranial com-
puted tomography if a clinically significant increased in-
tracranial pressure is suspected  [3] . Which clinical signs 
should prompt a cranial computed tomography is cur-
rently being debated for the management of patients with 
suspected bacterial meningitis  [20] . It is difficult to de-
velop guidelines for use in haematological patients due to 
highly individual circumstances, but fundoscopy may be 
omitted in patients without symptoms of increased pres-
sure.
 There are limitations to this study. Firstly, as acknowl-
edged, the majority of the respondents were senior staff 
members. This can imply a selection bias. Secondly, to 
limit the number of questions to the most common drugs, 
for which guidelines for cessation have been defined, we 
did not ask about the handling of novel, so-called direct, 
oral coagulation factor inhibitors such as dabigatran, ri-
varoxaban and apixaban.
 In conclusion, this study shows considerable variation 
in the routine handling of antithrombotic medication 
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and low platelet counts in patients before LP in Danish 
haematology departments. In general, practices adhere to 
current guidelines and the diversity may be explained by 
different opinions in the literature, especially on the 
platelet limit. There is a need for well-designed and high-
quality studies to establish an evidence-based approach to 
detect, guide and treat patients at risk of bleeding when 
in need of lumbar puncture. In addition, LP may be done 
routinely without fundoscopy.
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